chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaginal haemorrhage
Clinical narrative: 1/28/21, 2 hrs post vaccine: vaginal bleeding started, ended 3/12/21 despite continuing dura apri birth control daily. Last menstrual period was 6 days in June 2019. Birth control placebos are skipped to deter menstruation d/t endometriosis. 12 hrs post vaccine: nausea, diarrhea, migraine, low-grade fever (99.8), body aches and chills. Lasted 36 hrs post vaccine. On 2/3/21, I developed thrombosed hemorrhoids that didn't resolve until 2/26/21. Mild headaches daily until 3/12/21. Headaches continue to occur 4-7 days/wk to date. Other effects post vaccine continuing to date: constant mild-moderate aching in right wrist and elbow, daily severe fatigue, brain fog, dry eyes/mouth, eyesight deterioration (I have to get a revision on my lasik surgery)
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dysstasia, Pain in extremity, Spinal pain
Clinical narrative: Severe spinal pain, mild leg and hip soreness and pain. Spinal pain is mild when I sit in a fixed position. Sharp spinal pain flares up when bending or using lower back to make any movement. I could not stand up or get myself out of my bed without assistance until I received pain medication. Spinal pain persists from 8/23/2021 through 9/7/2021 (ongoing). ER visited on 8/27/2021 for treatment.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swollen armpit glands; lymph nodes; swollen armpit glands and lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 12:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included allergic to Penicillin. The patient did not receive any concomitant medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 12:00 (at the age of 50 -years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 15:00, the patient experienced swollen armpit glands; lymph nodes. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of swollen armpit glands; lymph nodes and included treatment with pain reliever. The clinical outcome of the events swollen armpit glands; lymph nodes was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 0.5
Sex: M
Vaccine: HPV9
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: No additional AE was noted; Caller states a 6 month-old patient was inadvertently administered a dose of the vaccine GARDASIL 9.; This spontaneous report has been received from a medical assistant, referring to a 6-month-old male patient. The patient's concurrent conditions, pertinent medical history, concomitant medication, previous drug and/or allergy reactions were not reported.  On 06-AUG-2021, the patient was inadvertently vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) at a dose of 0.5 milliliter, (vaccination scheme, route and anatomical location of administration were not provided; lot # 1687290 has been verified to be a valid lot number, and expiration date reported and established upon internal review as 06-SEP-2022) as prophylaxis (Product administered to patient of inappropriate age). The patient remained in the office for observation after vaccination and no additional adverse event was reported. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1687290; expirationdate: 06-SEP-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
Sex: U
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: no additional AE; expired dose of MMR II was administered; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 23-JUN-2021, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin) (M-M-R II) 1 dose, lot # S013536, expiry date: 02-MAY-2021 (formulation, strength, frequency, route of administration were not provided) for prophylaxis. No additional adverse events were reported.
Sex: U
Vaccine: HEP
Symptoms: Wrong product administered
Clinical narrative: No additional AE; reports that a pediatric dose ofRECOMBIV AX HB was administered to an adult patient; This spontaneous report was received from a nurse and refers to an adult patient of unknown age. The patient's concurrent conditions, medical history and concomitant therapies were not provided.    On 27-JUL-2021, the patient was vaccinated with a pediatric dose of hepatitis b vaccine (recombinant)(RECOMBIVAX HB), 0.5 milliliter (route was not provided), lot# was reported as T018888, expiration date 03-NOV-2022,  for prophylaxis.
Sex: U
Vaccine: HIBV
Symptoms: No adverse event, Product storage error
Clinical narrative: no other AE; pharmacist called to report a temperature excursion that occured on 13/AUG/2021, 14/AUG/2021 and 15/AUG/2021, PEDVAX HIB was given on 18/AUG/2021; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not reported.   On 18-AUG-2021, the patient was vaccinated with improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) 1 dose time, lot # T024020, expiration date reported as 13-MAR-2023, but upon internal validation it was established as 31-MAR-2023 for prophylaxis (exact doses, dose #, route of administration and anatomical location were not reported).  The temperature excursions occurred on 13-AUG-2021, 14-AUG-2021 and 15-AUG-2021. The temperature was as following: 10, 9.4 and 9.5 degrees Celsius for cumulative time 1 hour 27 min. There were no previous excursions reported. It was unknown if the digital data logger was involved. No signs or symptoms reported.
Sex: U
Vaccine: HPV9
Symptoms: Expired product administered, Product administration error
Clinical narrative: The consumer did not report any side effects. No additional AE reported; received GARDASIL-9 by mistake and was not scheduled to receive the vaccine.; AE Onset Date/Date PQC First identified: 8/26/2021 / Expiration date: 4/28/2021; This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. The patient's medical history, drug and allergy history, concurrent conditions, and concomitant medications were not reported.    On 26-AUG-2021, the patient was vaccinated with HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 milliliter (ml) (route of administration, vaccine scheme, and anatomical site of vaccination were not reported). Lot number U008600 is an invalid lot number for PV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9), confirmed by lot verification team, expiration date reported as 28-APR-2021 (expired product administered).   It was reported that the patient was administered HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) by mistake and was not scheduled to receive the vaccine (product administration error). No additional adverse event (AE) reported.
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No other adverse events reported.; Caller reports that an improperly stored dose of VARlVAX administered to patient on 25Aug2021; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, or concomitant medications were not reported.   On 25-AUG-2021, the patient was vaccinated with an improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) injection, 1 dose as prophylaxis (lot number U010398 which has been verified to be valid, expiration date reported and validated as 01-APR-2023) (route of administration and anatomical site of injection were not reported) (product storage error). The administered dose of the vaccine was stored at a temperature of -13.5 degrees Celsius (C) (also reported as -14 C to -10 C (-13.5 C)), during a time frame of 6 hours 39 minutes. There was no previous temperature excursion. No other adverse events were reported in the patient.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-2108USA008089:
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Condition aggravated, Herpes zoster, Incomplete course of vaccination
Clinical narrative: Mild case of shingles; got a single dose months ago. I am going to get the new one.; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (Family History) (patient's mother sufferred severe stabbing nerve pain (for 6 years), until she passed away).   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced shingles and incomplete course of vaccination. On an unknown date, the outcome of the shingles and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient for herself or himself. The age at vaccination was not reported. The patient stated that got shingles shot and got a mild case of shingles a few months ago. The patient stated that going to get newone, which led incomplete course of vaccination.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles on her left hip; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient got shingles vaccine and sometime later got shingles on her left hip. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Incomplete course of vaccination, Pain
Clinical narrative: got shingles years after the first shot,; Very very painful; got shingles years after the first shot,; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (got shingles on the lower vaccination protection).   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, several years after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced shingles, pain and incomplete course of vaccination. On an unknown date, the outcome of the shingles, pain and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient for herself/himself. The age at vaccination was not reported. The patient reported that, the very very painful,  get the vaccination he/she recommend it over being miserable with shingles. The patient stated that, he/she got shingles on the lower vaccination protection now this vaccination was higher protection for you 2 shots the old one was just one. The patient got shingles years after the first shot, because people come into grocery stores with everything all the time. Till the time of reporting, the patient did not receive the 2nd dose of Shingles vaccine, which led to incomplete course of vaccination.
Sex: U
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: Arm is still a lil sore; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 27th August 2021, the patient received the 1st dose of Shingles vaccine. In August 2021, less than a week after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.  Additional details were reported as follows; This case was reported by the patient for himself or herself. The age at vaccination was not reported. The patient stated that got shingles vaccine yesterday and experienced little arm sore but no other reactions. The reporter did not consented to follow up as no patients details provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: gotten it after the shot./2nd shot brought it on after 3 days; This case was reported by a consumer via interactive digital media  and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In February 2021, the patient received the 2nd dose of Shingles vaccine. In February 2021, 3 days after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  The case was reported by patient. The age at vaccination was not reported. The patient was waiting to hear from someone that shingles had gotten it after the shot.  The patient experienced shingles 3 days after the 2nd shot. Lasted for months. This was back in February. The case has been linked with the case US2021AMR184643 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR184643:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: rash; This case was reported by a consumer via interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was not recovered/not resolved.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The patient experienced rash after 1st dose. The patient asked if she/he get the Shingles 2nd dose when the rash clears up .
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Rash
Clinical narrative: Got the first and had an outbreak; Pn is undescibable; This case was reported by a consumer via  interactive digital media and described the occurrence of shingles in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, several days after receiving Shingles vaccine, the patient experienced shingles and pain. On an unknown date, the outcome of the shingles was recovered/resolved and the outcome of the pain was unknown.   It was unknown if the reporter considered the shingles and pain to be related to Shingles vaccine.  Additional details provided were as follows: The case was reported by patient herself. The age at vaccination was not reported. The patient received the 1st shot and actually had an outbreak of shingles a few days later and it did not last as long though. The patient would get the 2nd shot as 3 months in between shot 1 and 2. The patient was informed by many doctors that it did not prevent them, just keeps the frequency of how often way better.  The patient stated that the pain was undesirable. The patient had birthed 3 kiddos, and in her case and opinion, the pain was nothing compared to shingles. The patient stated that she suffered for years before finding out through her pharmacist recently that her insurance would cover it at this time, and she was excited for 2nd shot. Follow-up would not be possible as no contact details available. The case was linked with case US2021AMR184639 and US2021AMR184658, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR184639:Same reporter. Hearsay case 1. US-GLAXOSMITHKLINE-US2021AMR184658:Same reporter. Hearsay case 2.
Age: 88.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: shingles; This case was reported by a consumer via  interactive digital media and described the occurrence of shingles in a 88-year-old male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 3 weeks after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details provided were as follows: The case was reported by patient's son/daughter. The reporter reported that the shot did not work for his/her father and experienced shingles 3 weeks later. Follow-up would not be possible as no contact details available.
Sex: U
Vaccine: VARZOS
Symptoms: Lymph node pain
Clinical narrative: lymph nodes to hurt; This case was reported by a consumer via interactive digital media and described the occurrence of lymph node pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced lymph node pain. On an unknown date, the outcome of the lymph node pain was unknown.   The reporter considered the lymph node pain to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient received the dose of Shingrix and stated that it caused his/her lymph node to hurt. The follow-up would not possible as no contact details were available.
Sex: M
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: didn't recieve the 2nd part of his shingles vaccine!!; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The reporter was the patient's wife. The age at vaccination was not applicable for this report. The reporter stated that, till the time of reporting, the patient did not receive 2nd dose of Havrix, which led to incomplete course of vaccination. The reporter stated that, her husband got the the first shot and went to get the second one the other day and find out it was not coverd and had a 191.00 price tag needless to say he did not recieve the 2nd part of his shingles vaccine. The reporter consented to follow up.
Sex: U
Vaccine: VARZOS
Symptoms: Product supply issue
Clinical narrative: shortage and I got the second shot about 8-10 months after the first; This case was reported by a consumer via interactive digital media and described the occurrence of product supply issue in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced product supply issue. On an unknown date, the outcome of the product supply issue was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The reporter stated that, due to shortage, got 2nd dose of Shingrix vaccine about 8 to 10 months after the first, which led to product supply issue. The patient had 1st dose about 3 months ago.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash
Clinical narrative: Rash; Shingles; This case was reported by a consumer via(Shingrix ) interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On 19th July 2021, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the patient experienced rash. On an unknown date, the outcome of the shingles was unknown and the outcome of the rash was recovered/resolved.   It was unknown if the reporter considered the shingles and rash to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient for herself or himself. The age at vaccination was not reported. The patient had the 1st Shingles vaccine, but didn't get the 2nd shot due to surgery and amp; more. The patient got shingles on 19th July 2021. The patient was told that the patient need 1 shot and amp; when the patient's rash had completely gone.
Sex: U
Vaccine: VARZOS
Symptoms: Headache, Herpes zoster
Clinical narrative: Had them around my eye; the pain in that quarter of my head; This case was reported by a consumer via )interactive digital media and described the occurrence of shingles in a 72-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles and headache. On an unknown date, the outcome of the shingles and headache were recovered/resolved.   It was unknown if the reporter considered the shingles and headache to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient for herself/himself. The age at vaccination was not reported. The patient had shingles vaccine and got shingles around eye and the pain in that quarter of head was terrible. The patient had to make several trip to eye doctor to make sure they didn't go into eye this was after having the first shingle shot. The patient also got the second dose
Sex: U
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: Right arm was sore; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Concomitant products included PNEUMOCOCCAL VACCINE (PNEUMONIA SHOT).   On 25th August 2021, the patient received the 1st dose of Shingles vaccine. In August 2021, less than a week after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient for himself or herself. The age at vaccination was not reported. The patient reported that the got Pneumonia shot in left arm. The patient also reported that the got shingles vaccine in right arm right and stated that the right arm was sore for 2 days.  No reddish and no fever. The patient's 2nd shot was due in October 2021. The patient's contacts details was not provided so follow up was not possible.
Sex: U
Vaccine: VARZOS
Symptoms: Monoplegia, Pain
Clinical narrative: paralyzed my arm and side; Excruciating pain; This case was reported by a consumer via media and described the occurrence of arm paralysis in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced arm paralysis (serious criteria GSK medically significant) and pain. On an unknown date, the outcome of the arm paralysis and pain were recovered/resolved.   It was unknown if the reporter considered the arm paralysis and pain to be related to Shingles vaccine.  Additional details were provided are as follows: The case was reported by patient himself/herself. The age at vaccination was not reported. The patient decided to get the shot and had bad choice and experienced excruciating pain and paralyzed arm and side which lasted for 2 days. The reporter stated not to get any more vaccine. The follow up would not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Second shot 2 or 3 years after the first; This case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received 3 years ago).   In August 2021, the patient received the 2nd dose of Shingrix. In August 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The reporter stated that, received 2nd dose of Shingrix late than the recommended time interval, which led to lengthening of vaccination schedule. The reporter asked did need to take 3rd shot.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 3 weeks after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows The case was reported by the patient's neighbor. The age at vaccination was not reported. The patient received Shingles vaccine last year from the date of reporting. For the tolerance of other Shingles vaccine booster dose, refer linked case US2021AMR186113.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR186113:same patient/ same reporter
Sex: M
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: after 2 years of 1st dose could take 2nd dose; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received 2 years prior to the report).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose, which led to incomplete course of vaccination.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: shingles, two weeks after shingles vaccine; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 weeks after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient's daughter/son. The age at vaccination was not reported. The patient developed shingles two weeks after her shingles vaccine. The follow-up would not possible as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: sore arm; This case was reported by a other health professional and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were reported as follows: The case was reported by the patient. Age at vaccination was not reported. The patient stated that with her 1st Shingrix shot she had a sore arm which was not a big deal. No contact details were reported. For tolerance in 2nd dose refer case US2021AMR186215.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR186215:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: got 2 vaccines, sore arm; This case was reported by a consumer via  interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got the 1st vaccines of shingles and experienced reaction was a sore arm. The follow-up would not possible as no contact details were available. For tolerance of 2nd dose refer case US2021AMR186349.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR186349:2nd dose
Sex: U
Vaccine: VARZOS
Symptoms: Malaise
Clinical narrative: Ill; This case was reported by a consumer via  interactive digital media and described the occurrence of unwell in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced unwell. On an unknown date, the outcome of the unwell was unknown.   It was unknown if the reporter considered the unwell to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the reporter whom he/she knew. The age at vaccination was not reported. The reporter stated that shot could make you feel like you were dying. The reporter stated that he/she knew patient who got Shingles vaccine and got extremely ill. The case was linked with US2021AMR186615 reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR186615:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Malaise
Clinical narrative: ill; This case was reported by a consumer via interactive digital media and described the occurrence of unwell in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced unwell. On an unknown date, the outcome of the unwell was unknown.   It was unknown if the reporter considered the unwell to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the reporter whom he/she knew. The age at vaccination was not reported. The reporter stated that shot could make you feel like you were dying. The reporter stated that he/she knew patient who got Shingles vaccine and got extremely ill. The case was linked with US2021AMR186613 reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR186613:same reporter
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient's wife. The age at vaccination was not reported. The patient received all the Shingles shots. After receiving Shingles vaccine, the patient got shingles twice. This case was considered as suspected vaccination failure, since the details regarding time to onset for event and laboratory confirmation of shingles were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles / have them now; This case was reported by a consumer via interactive digital media  and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. The patient received Shingles vaccine couple of years ago from the date of reporting. Ater receiving Shingles vaccine, the patient had shingles. The patient stated that, it sucked. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided. This case had been linked with case US2021AMR184719, reported by the same reporter.
Sex: U
Vaccine: VARZOS
Symptoms: Condition aggravated, Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; getting them; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (got every year since 4 years ago from the date of reporting).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. The patient got shingles every year for last 4 years from the date of reporting. After receiving Shingles vaccine, the patient still got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Ophthalmic herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; eye shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On 10th January 2021, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and ophthalmic herpes zoster (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the ophthalmic herpes zoster was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and ophthalmic herpes zoster to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient had been suffering with eye shingles since 10th January 2021. The patient stated that, Shingles vaccine did not prevent this from happening. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Incomplete course of vaccination, Myalgia
Clinical narrative: myalgia in shoulders and neck; Provider stated she will not give 2nd dose; This case was reported by a physician and described the occurrence of myalgia in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included arthritis (patient has pre-existing arthritis).   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced myalgia and incomplete course of vaccination. On an unknown date, the outcome of the myalgia was recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   The reporter considered the myalgia to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient has pre-existing arthritis. The patient received Shingrix and experienced sever myalgia in shoulders and neck. The reporter believed this severe myalgia was a result of vaccination with Shingrix. The patient did go to emergency room for care. The patient's myalgia resolved after a few days. The provider stated she would not give 2nd dose, which led to incomplete course of vaccination. No additional information was provided. The reporter did not consent to follow up
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovering/resolving.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient's wife. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. At the time of reporting, the patient was recovering. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Sex: F
Vaccine: VARZOS
Symptoms: Hypersensitivity
Clinical narrative: Allergic rex; This case was reported by a consumer via interactive digital media and described the occurrence of allergic reaction in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced allergic reaction. On an unknown date, the outcome of the allergic reaction was unknown.   It was unknown if the reporter considered the allergic reaction to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix vaccine and experienced mild allergic reaction. The reporter wanted to know that should he/she get the 2nd dose. The follow up would not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: First shot over 2 years ago; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st shot received over 2 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not applicable for this report. The patient stated he/she had 1st Shingrix shot and asking advised on whether to get 2nd shot. Till the time of reporting, the patient did not receive the 2nd dose of the vaccine, which led to incomplete course of vaccination. The follow-up would not possible as no contact details were available.
Sex: M
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: First shot 2 years ago, not advised to get a 2nd; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date 2 years ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. This case was reported by patient's wife. Till the time of reporting, the patient did not received 2nd dose, which led to incomplete course of vaccination. This case is linked with the case US2021AMR187241, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR187241:Same reporter. Reporter's case.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient was the sister in law of the reporter. The age at vaccination was not reported. The reporter stated that, his/her sister in law got the Shingles vaccine and guess what, she got a bad case of shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of primary vaccination schedule, time to onset for event and laboratory confirmation for shingles were not provided.